← Back to Clinical Trials
Recruiting NCT04956133

NCT04956133 IMPACT: IMplementation of Physical Activity for Children and Adolescents on Treatment

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT04956133
Status Recruiting
Phase
Sponsor University of Calgary
Condition Pediatric Cancer
Study Type INTERVENTIONAL
Enrollment 250 participants
Start Date 2022-08-03
Primary Completion 2027-12-01

Trial Parameters

Condition Pediatric Cancer
Sponsor University of Calgary
Study Type INTERVENTIONAL
Phase N/A
Enrollment 250
Sex ALL
Min Age 5 Years
Max Age 18 Years
Start Date 2022-08-03
Completion 2027-12-01
Interventions
Physical Activity

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

Physical activity can enhance well-being among youth diagnosed with oncological or hematological diseases. We developed a tailored, 1:1, online physical activity program (i.e., IMPACT), to promote physical activity in this cohort. The proposed single-group, mixed-methods project will assess the effect of IMPACT and explore markers of implementation.

Eligibility Criteria

Inclusion Criteria: 1. Children or adolescents between the ages of 5-18 years at enrollment and at least one parent (defined as a caregiver; biological or otherwise) 2. Diagnosed with any oncological and/or hematological diagnosis 3. Currently receiving or scheduled to receive any treatment for any oncological and/or hematological diagnosis or completed treatment \<3 months Exclusion Criteria: 1. Completed all treatment for their oncological or hematological diagnosis \>3 months 2. Unable to participate in physical activity as assessed by the patients' healthcare team or physical activity specialist 3. Parent and/or patient cannot understand verbal English 4. Parent is unwilling to be present (i.e., at home, in the same room depending on participant age and functional ability) during the physical activity sessions (required to ensure safety of the child/adolescent)

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology